Final-Program-ATS-2023-AP.vp

WEDNESDAY • MAY 24

339

1:24 Lung Microstructure and Regional Function of Quantitative Emphysema Subtypes on Coregistered Computed Tomography and Hyperpolarized Gas Magnetic Resonance Imaging Scans: The M E S A - C O P D Study/ W. Shen, New York, NY 1:36 Regional Alterations in Air-trapping Associated With the Early Progression of COPD/ R. Baron, Philadelphia, PA 1:48 The Impact of Chronic Obstructive Lung Disease (COPD) on Lung Cancer in the Pittsburgh Lung Screening Study (PLUSS)/ H. Strollo, Pittsburgh, PA

1:00 Lactylation Mediated Attenuation of Inflammation in Acute Lung Injury/ C.U. Vohwinkel, Aurora, CO 1:12 Endothelial SDF1 Is the Endogenous Activator of Endothelial Pyroptosis Mediating Inflammatory Vascular Injury in Sepsis and Associated Acute Respiratory Distress Syndrome/ X. Zhang, Chicago, IL 1:24 Fra-1 Activation by Neonatal Hyperoxia Maintains Proinflammatory Macrophage Phenotype and Obstructs the Pro-resolution Leading to Alveolar Remodeling/ S.P. Reddy, Chicago, IL 1:36 Maintenance DNA Methylation Stabilizes Induced Regulatory T Cells/ A.M. Joudi, Chicago, IL 1:48 ERG Deletion in Lymphatic Endothelial Cells Increases Inflammation and Lymphatic Remodeling in Mouse Lungs/ A. Chakraborty, Boston, MA

BASIC • TRANSLATIONAL MINI SYMPOSIUM

D98

UPDATE ON THE “OMICS” OF LUNG CANCER: A TRANSLATIONAL SESSION

BASIC • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

12:00 p.m. - 2:00 p.m.

Walter E. Washington Convention Center Room 102 A-B (Street Level)

Chairing: E. Ostrin, MD, PhD, Houston, TX N. Al Nasrallah, MD, Indianapolis, IN Oral Presentations: 12:00 Lung Tissue Transcriptome as Predictor of Recurrence in Early-stage Non-small Cell Lung Cancer/ F. Darawshy, New York, NY 12:12 Immune Tone of Tumor-draining Lymph Nodes in Non-small Cell Lung Cancer/ B. Kwok, New York, NY 12:24 Elevated Derived Neutrophil-to-Lymphocyte Ratio Is Associated With Lower Airway Dysbiosis in Non-Small Cell Lung Cancer/ M.S. Dreier, New York, NY 12:36 Mediastinal Lymph Node and Airway Microbiome Associations in Lung Cancer and Sarcoidosis/ S. Shojaee, Nashville, TN 12:48 LKB1-LIF Signaling Axis Promotes an Immunosuppressive Microenvironment in Lung Adenocarcinoma/ R. Pillai, New York, NY 1:00 Clinical Usefulness of Serum KL-6 Test for Predicting Occurrence and Assessing Severity of Treatment-related ILD/ H.K. Park, Hwasun, Korea, Republic of 1:12 Tsc2 Heterozygosity Augments Wnt 1 Mediated Breast Tumor Initiation and Metastatic Colonization in the Lung/ U.J. Unachukwu, New York, NY 1:24 Tumoral Genetic Mutations Correlated With Mast Cell Infiltration in Early-stage Lung Adenocarcinoma/ M.N. Kammer, Nashville, TN

D97

IMPACT OF COPD ACROSS THE LIFESPAN

12:00 p.m. - 2:00 p.m.

Walter E. Washington Convention Center Room 202 A (Level 2)

Chairing: J.C. Woods, PhD, ATSF, Cincinnati, OH Oral Presentations: 12:00 Clinical Trajectory Analysis With Longitudinal Validation in COPD: A COPDGene Study/ A.J. Bell, Ann Arbor, MI 12:12 MRI and CT Measurements Uniquely Explain All-cause Mortality in Ex-smokers With and Without COPD/ M. Sharma, London, Canada 12:24 Longitudinal Assessment of Ultrasound-derived Diaphragm Contractile Reserve in Acute Exacerbations of COPD/ A. Valin-Thorburn, Montreal, Canada 12:36 Does Respiratory Muscle Strength Substantially Improve Prognostic Evaluation and Risk Stratification in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD)? A 42-Month Follow-up Analysis/ R.N. Silva, Sao Carlos, Brazil 12:48 Feature-based PRM for Robust Disease Classification in COPD/ S. Ram, Ann Arbor, MI 1:00 PRM and Topological Imaging Features From HRCT Can Identify Prism Patients Who Progress to COPD/ R. Geng, South San Francisco, CA 1:12 A Genome-wide Association Study of Dysanapsis Among Adults and Children/ C. Debban, Charlottesville, VA

ATS 2023 • Washington, DC